Clinical Trials on Ankle Joint in Japan

Total 289 results

Santen Pharmaceutical Co., Ltd.

Completed

To Investigate the Safety and Efficacy of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma

Japan
Alcon, a Novartis Company

Completed

Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic Solution

Ocular Hypertension | Open-Angle Glaucoma

Japan
Santen Pharmaceutical Co., Ltd.

Completed

Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma

Japan
Alcon Research

Completed

Safety and Efficacy of Travoprost/Timolol BAC-free

Ocular Hypertension | Open-Angle Glaucoma

Japan
Santen Pharmaceutical Co., Ltd.

Completed

A Long-term Study of DE-117 Ophthalmic Solution Monotherapy and Concomitant Use of DE-117 Ophthalmic Solution With Timolol Ophthalmic Solution in Patients With OAG or OH: RENGE Study

Open Angle Glaucoma or Ocular Hypertension

Japan
Santen Pharmaceutical Co., Ltd.

Completed

DE-111 Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension

Open Angle Glaucoma or Ocular Hypertension

Japan
Santen Pharmaceutical Co., Ltd.

Completed

A Study Assessing the Safety and Efficacy of DE-117 in Subjects With POAG or OH Who Are Non-/Low-responders to Latanoprost: FUJI Study

Primary Open Angle Glaucoma or Ocular Hypertension

Japan
Santen Pharmaceutical Co., Ltd.

Completed

DE-111 Against Timolol Ophthalmic Solution 0.5%

Ocular Hypertension | Open Angle Glaucoma

Japan
Santen Pharmaceutical Co., Ltd.

Completed

DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5%

Ocular Hypertension | Open Angle Glaucoma

Japan
Santen Pharmaceutical Co., Ltd.

Completed

A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study-

Primary Open Angle Glaucoma | Ocular Hypertension

Japan
Aerie Pharmaceuticals

Completed

Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

Primary Open Angle Glaucoma | Ocular Hypertension

Japan
Santen Pharmaceutical Co., Ltd.

Recruiting

A Long Term Study of STN1012600 in Subjects With Open Angle Glaucoma or Ocular Hypertension

Open Angle Glaucoma, Ocular Hypertension

Japan
Okayama University

Unknown

Evaluation of Optimal Dose of Local Anesthetics for Patient Controlled Continuous Femoral Nerve Block

Arthropathy of Knee Joint

Japan
Santen Pharmaceutical Co., Ltd.

Completed

A Comparative Confirmatory Study of STN1012600 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

Primary Open Angle Glaucoma, Ocular Hypertension

Japan
Stryker Japan K.K.

Completed

Navigation With X3 vs Non-Navigation With X3 Study

Degenerative Joint Disease

Japan
Johnson & Johnson K.K. Medical Company

Completed

Follow-up Study After Bankart Repair Using MG-1

Shoulder Dislocation

Japan
Shinshu University

Recruiting

To Examine Whether or Not the Primary Causes of OA or RA Might be Bone Alterations

Osteoarthritis of Multiple Joints | Progression of Rheumatoid Arthritis

Japan
Zimmer Biomet

Completed

A Study on M2a Magnum Total Hip Arthroplasty

Avascular Necrosis | Degenerative Joint Disease

Japan
Shinshu University

Recruiting

Non-weight Bearing in Hip Joint With Accompanying Joint Pain Might Not Progress Radiographic OA

Hip OA

Japan
Tokyo Medical University

Enrolling by invitation

Quantitative Assessment of Distal Radioulnar Joint Stability With Pressure-Monitor Ultrasonography

Triangular Fibrocartilage Complex Injury | Distal Radioulnar Joint Sprain

Japan
Zimmer Biomet
Biomet Japan, Inc.

Completed

Review on Minimally Invasive Skin Incision in Vanguard PS Artificial Knee Joint System

Gonarthrosis Patients Who Need Artificial Knee Joint Total Replacement

Japan
Pfizer

Completed

Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan)

Arthritis | Rheumatoid

Japan
Osaka Metropolitan University
Mayo Clinic; Istituto Ortopedico Rizzoli; Hospital for Special Surgery, New York

Active, not recruiting

Polyethylene Wear Particle Analysis of TKA

Total Knee Arthroplasty | Wear of Articular Bearing Surface of Prosthetic Joint

Japan
Tokyo Medical and Dental University

Completed

Randomized Clinical Trial of Treatment for Temporomandibular Joint (TMJ) Disc Displacement

Temporomandibular Disorders | Herniated Disk

Japan
Johnson & Johnson K.K. Medical Company

Completed

Open-Label Study for Shoulder Dislocation Using MG-1 (MG-1)

Shoulder Dislocation

Japan
Bausch & Lomb Incorporated

Completed

A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension.

Primary Open Angle Glaucoma | Ocular Hypertension

Japan
Stryker Japan K.K.

Unknown

Large Head X3 Study

Degenerative Joint Disease

Japan
Zimmer Biomet

Completed

Vanguard TKA With KneeAlign 2 and Without KneeAlign 2

Osteoarthritis, Knee

Japan
Pfizer

Completed

Methotrexate (Rheumatrex) High Dose Special Investigation (Regulatory Post Marketing Commitment Plan)

Arthritis | Rheumatoid | High Dose

Japan
RS Medical
Accelerated Care Plus; Research Institute of Health and Science (RIHSE)

Completed

Patterned Electrical Neuromuscular Stimulation and Therapeutic Exercise for Osteoarthritis of the Knee: Pilot Study

Knee Osteoarthritis

Japan
Sanofi

Completed

Safety, Tolerability and Pharmacokinetics of SAR113945 in Japanese Patients With Knee Osteoarthritis

Knee Osteoarthritis

Japan
Chiba University

Completed

Optimization of Infliximab Withdrawal Strategy for Rheumatoid Arthritis (OPTIWIT)

Arthritis, Rheumatoid

Japan
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd

Completed

Study of the Safety of Orencia in Japanese Children and Adolescents With Active Juvenile Arthritis of Unknown Origin

Undifferentiated Arthritis

Japan
Pfizer

Completed

Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid Arthritis

Arthritis, Rheumatoid

Japan
Santen Inc.

Completed

A Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular Hypertension- Angel Study

Open-angle Glaucoma, Ocular Hypertension

United States, Japan
Eli Lilly and Company
Shionogi

Completed

An Extension Study of Duloxetine in Osteoarthritis and Knee Pain (Extension of F1J-JE-HMGX, NCT02248480)

Osteoarthritis of the Knee

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

An Extension Study of TS-152 in Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Daiichi Sankyo, Inc.

Completed

AMG 162 (Denosumab) Phase 3 Study (DESIRABLE Study) in Participants With Rheumatoid Arthritis on Disease-modifying Antirheumatic Drugs (DMARDs) Treatment (DESIRABLE)

Rheumatoid Arthritis

Japan
Pfizer

Completed

Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan

Rheumatoid Arthritis

Japan
Pfizer

Active, not recruiting

Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)

Rheumatoid Arthritis

Japan
Pfizer

Completed

Tofacitinib (Xeljanz) Special Investigation for Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Japan Biological Agent Study Integrated Consortium

Completed

Efficacy and Safety of Etanercept in Active RA Despite Methotrexate Therapy in Japan (JESMR)

Rheumatoid Arthritis

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety Study of MP-435 in Combination With Methotrexate (MTX) in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Pfizer

Completed

Enbrel-Juvenile Idiopathic Arthritis (JIA) Use Results Survey [All-Case Surveillance] (Enbrel-JIA)

Juvenile Idiopathic Arthritis

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis.

Rheumatoid Arthritis

Japan
Novartis Pharmaceuticals

Completed

Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis Participants

Osteoarthritis | Knee

Japan
Zimmer Biomet

Recruiting

ROSA Knee Intraoperative Planning Flexibility Study (IntraOP)

Rheumatoid Arthritis | Osteo Arthritis Knee

Japan
Eli Lilly and Company
Shionogi

Completed

A Study of Duloxetine (LY248686) in Participants With Chronic Osteoarthritis and Knee Pain in Japan

Osteoarthritis of the Knee

Japan
Shinshu University

Recruiting

Usefulness of Non TNF Usage in RA Patients

Rheumatoid Arthritis

Japan
Shinshu University

Recruiting

Examination of Efficacy and Safety of Baricitinib in RA Patients

Rheumatoid Arthritis

Japan

3

Subscribe